TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Abera Bioscience AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
0
|
2,680
|
0 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-1,134
|
-16,935
|
-18,332 |
| EBITDA |
-1,092
|
-17,018
|
-18,344 |
| Total assets |
14,029
|
9,472
|
18,515 |
| Current assets |
10,980
|
7,535
|
16,729 |
| Current liabilities |
5,102
|
3,740
|
2,644 |
| Equity capital |
8,927
|
5,732
|
15,871 |
| - share capital |
1,266
|
1,172
|
977 |
| Employees (average) |
5
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
63.6%
|
60.5%
|
85.7% |
| Turnover per employee |
0
|
447
|
0 |
| Profit as a percentage of turnover | -631.9% | ||
| Return on assets (ROA) |
-8.1%
|
-178.8%
|
-99.0% |
| Current ratio |
215.2%
|
201.5%
|
632.7% |
| Return on equity (ROE) |
-12.7%
|
-295.4%
|
-115.5% |
| Change turnover | |||
| Change turnover % | -100% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
0%
|
20% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.